Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 228,371 | 230,468 | 235,637 | 228,031 | 253,155 |
| Cost of Goods | 58,157 | 64,404 | 62,682 | 55,093 | 63,701 |
| Gross Profit | 170,214 | 166,064 | 172,955 | 172,938 | 189,454 |
| Operating Expenses | 133,072 | 135,502 | 140,997 | 149,311 | 188,865 |
| Operating Income | 37,299 | 30,966 | 32,640 | 23,720 | 1,290 |
| Interest Expense | 6,622 | 12,452 | 13,330 | 11,592 | 12,807 |
| Other Income | 5,105 | 5,586 | 3,364 | -11,671 | -17,285 |
| Pre-tax Income | 35,782 | 24,100 | 22,674 | 457 | -28,802 |
| Income Tax | 4,671 | -6,178 | 1,083 | 455 | 324 |
| Net Income Continuous | 31,111 | 30,278 | 21,591 | 2 | -29,126 |
| Net Income | $31,111 | $30,278 | $21,591 | $2 | $-29,126 |
| EPS Basic Total Ops | 0.62 | 0.62 | 0.46 | 0.00 | -0.72 |
| EPS Basic Continuous Ops | 0.62 | 0.62 | 0.46 | 0.00 | -0.72 |
| EPS Diluted Total Ops | 0.61 | 0.62 | 0.45 | 0.00 | -0.72 |
| EPS Diluted Continuous Ops | 0.61 | 0.62 | 0.45 | 0.00 | -0.72 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.62 | 0.45 | 0.00 | -0.72 |
| EBITDA(a) | $48,237 | $42,490 | $44,159 | $33,560 | $12,595 |